GlycoFlux™ Human PGAM2 Overexpression HepG2 Cell Line (CAT#: GLJF-0925-JF662)

Description	GlycoFlux™ human PGAM2 overexpression HepG2 cell line is a stable glycoengineered line that constitutively overexpresses muscle phosphoglycerate mutase, shifting 3-phosphoglycerate/2-phosphoglycerate balance and downstream pyruvate/lactate output. This flux control uncouples carbon allocation to serine/one-carbon pathways and UDP-sugar biosynthesis, allowing precise evaluation of impacts on ER quality control, Golgi residence time, and glycoprotein secretion under high-throughput glycolysis.
Product Type	Overexpression Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:4~1:6
Cell Line	HepG2
Primary Disease	Hepatoblastoma
Lineage	Liver
Lineage Subtype	Hepatoblastoma

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	qPCR, Sanger Sequencing
Culture Medium	DMEM & FBS & Glutamine
Application	Mechanistic studies; Exploration of glycosylation and signaling pathways in cancer, metabolic, and immune-related diseases; Drug target validation and other functional assays.
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	PGAM2
Full Name	Phosphoglycerate Mutase 2
Alternative Name	GSD10; PGAMM; PGAM-M
Location	7p13
Gene ID	5224
Summary	Phosphoglycerate mutase (PGAM) catalyzes the interconversion of 3-phosphoglycerate and 2-phosphoglycerate in glycolysis. This gene encodes the muscle-specific subunit, and mutations cause glycogen storage disease X.